The panel will be moderated and jointly led by leaders from McKinsey & Co. and Morrison & Foerster, who will share their respective perspectives on the opportunities gene editing creates in an evolving technological and regulatory landscape worldwide. The panelists will address key questions relating to:
What is possible through gene editing? How does it differ from traditional GMO tech?
What is the outlook for gene editing in Europe and China?
What is the regulatory landscape in the US?
Josh Katz - Partner, McKinsey & Company
Michael Ward - Partner, Morrison & Foerster
Stacy Amin - Partner, Morrison & Foerster
Tom Brennan - Associate Partner, McKinsey & Company
Shane Bryan - Associate Partner, McKinsey & Company
Wolfgang Schönig - Partner, Morrison & Foerster
William (Bill) Tarantino - Partner, Morrison & Foerster